LEI 5493007TDQLA2Z7RB387

AMGEN

Group parent: AMGEN INC.AMGN · UN

Awards tracked

24

Value

€29.99M

Countries

PL, BE, ES

Download sample CSV

Contract awards & public grants

Poland – Antineoplastic agents – Dostawa produktów leczniczych- Sotorasibum → Amgen

Centrum Onkologii im. Franciszka Łukaszczyka w Bydgoszczy · PL · Tender · 2026-09-07

€630,275

Poland – Immunoglobulins – Immunoglobuliny oraz inne produkty lecznicze → amgen

Wojewódzki Specjalistyczny Szpital Dziecięcy im. prof. dr Stanisława Popowskiego w Olsztynie · PL · Tender · 2026-08-25

€216,279

Poland – Pharmaceutical products – Dostawa produktów leczniczych (chemioterapia, programy lekowe) - 71 części → Amgen

Instytut Hematologii i Transfuzjologii · PL · Tender · 2026-08-12

€803,719

Belgium – Pharmaceutical products – Denosumab SC → Amgen NV

AZ Delta vzw · BE · Tender · 2026-07-09

€233,448

Spain – Various medicinal products – Adjudicación del Contrato Específico del Medicamento USTEKINUMAB, derivado del Sistema Dinámico de Adqu → AMGEN SA

Fundació Hospital d'Olot i Comarcal de la Garrotxa · ES · Tender · 2026-06-29

€249,366

Poland – Pharmaceutical products – Dostawa leków i leków z programów lekowych na potrzeby 118 Szpitala Wojskowego z Przychodnią SPZOZ w Ełku → Amgen

118 Szpital Wojskowy z Przychodnią Samodzielny Publiczny Zakład Opieki Zdrowotnej w Ełku · PL · Tender · 2026-06-08

€40,842

Poland – Pharmaceutical products – Postępowanie o udzielenie zamówienia publicznego w trybie przetargu nieograniczonego na dostawę leków z p → Amgen

Uniwersytecki Szpital Dziecięcy w Lublinie · PL · Tender · 2026-06-01

€38,049

Belgium – Medicinal products for the blood, blood-forming organs and the cardiovascular system – Aankoop darbepoëtine alfa → AMGEN NV

AZ Alma · BE · Tender · 2026-04-30

€206,984

Belgium – Various medicinal products – Denosumab → AMGEN NV

VITAZ vzw · BE · Tender · 2026-04-01

€7,551

Belgium – Pharmaceutical products – Leveren van een terugbetaalde vorm van Bevacizumab 100 mg/4 ml en 400 mg/ 16ml voor intraveneus gebruik → AMGEN

UZ Leuven · BE · Tender · 2026-03-19

€1.54M

Belgium – Pharmaceutical products – Raamovereenkomst voor het leveren van middelen in verband met de bloedvorming (neutropenie) → AMGEN NV

Universitair Ziekenhuis Gent · BE · Tender · 2026-02-18

€120,155

Unifying Framework for Patient-centred Clinical-study Endpoints derived from Digital Health Technologies → AMGEN

European Commission · BE · Grant · 2025-11-03

—

101218845 - UNIFIED - UNIFYING FRAMEWORK FOR PATIENT-CENTRED CLINICAL-STUDY ENDPOINTS DERIVED FROM DIGITAL HEALTH TECHNOLOGIES → AMGEN

IMI - Innov.Health Initiative · BE · Grant · 2025-11-01

€12.6M

101191967 - GREG - TESTING, IMPROVING, AND CO-CREATING GUIDANCE AND TOOLS FOR REAL WORLD EVIDENCE GENERATION IN EUROPE AND USE FOR DECISION-MAKING IN → AMGEN

IMI - Innov.Health Initiative · BE · Grant · 2025-05-01

€13.3M

Testing, improving, and co-creating Guidance and Tools for Real World Evidence Generation in Europe and use for Decision-Making in Europe: GREG → AMGEN

European Commission · BE · Grant · 2025-04-28

—

REpresentative Clinical Research - ADvancing Inclusivity in Europe → AMGEN

European Commission · BE · Grant · 2024-12-05

—

Synthetic hEalthcare dAta goveRnanCe Hub → AMGEN

European Commission · BE · Grant · 2024-09-13

—

INDIVIDUALISED CARE FROM EARLY RISK OF CARDIOVASCULAR DISEASE TO ESTABLISHED HEART FAILURE → AMGEN

European Commission · BE · Grant · 2023-10-20

—

Optimal treatment for patients with solid tumours in Europe through Artificial intelligence → AMGEN

European Commission · BE · Grant · 2021-10-18

—

Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement → AMGEN

European Commission · BE · Grant · 2019-03-22

—

ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064 → AMGEN

European Commission · BE · Grant · 2017-05-18

—

Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 → AMGEN

European Commission · BE · Grant · 2017-01-30

—

Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 → AMGEN

European Commission · BE · Grant · 2016-12-22

—

Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: → AMGEN

European Commission · BE · Grant · 2015-09-02

—

Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.